Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BFPET
DRUG
2 trials
Sponsors
Fluoropharma, Inc.
Conditions
Coronary Artery Disease
Phase 1
A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET
Completed
NCT00733460
Fluoropharma, Inc.
Coronary Artery Disease
Start: 2008-03-31
End: 2012-01-31
Updated: 2013-06-10
Phase 2
BFPET for Regional Myocardial Perfusion Imaging
NCT02252783
Fluoropharma, Inc.
Coronary Artery Disease
Start: 2018-10-01
End: 2019-09-30
Target: 40
Updated: 2018-08-01